Aptevo Therapeutics Inc.
APVO
$4.83
-$0.02-0.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.97M | -26.47M | -24.03M | -23.70M | -24.13M |
| Total Depreciation and Amortization | 240.00K | 230.00K | 265.00K | 307.00K | 352.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19M | 1.12M | 1.19M | 1.63M | 2.17M |
| Change in Net Operating Assets | -1.05M | -994.00K | -2.08M | -1.94M | -2.18M |
| Cash from Operations | -25.59M | -26.12M | -24.65M | -23.71M | -23.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.50M | 38.95M | 25.52M | 15.13M | 15.13M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 472.00K | 472.00K | 472.00K | 469.00K |
| Cash from Financing | 38.50M | 39.42M | 25.99M | 15.60M | 15.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.91M | 13.31M | 1.34M | -8.11M | -8.19M |